Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Playing It Safe

As more companies develop antibody-drug conjugates, there is growing focus on the production complexities such as handling their cytotoxic aspect and the role of contract manufacturing organisations in ensuring quality control.

Dr Cynthia Wooge, SAFC (June 2014)

Keywords: Antibody-drug conjugates, Monoclonal antibodies, Highly potent active pharmaceutical ingredient, Cytotoxic molecule

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |